The results of research, coordinated by the State University of Milan in collaboration with the University of Genoa and financed by AriSLA, have been published in the British Journal of Pharmacology, indicating the repositioning of an anti-asthmatic drug as a possible new therapeutic approach for amyotrophic lateral sclerosis.


The full article is on UniGe.life, the magazine of the University of Genoa.